Qing Sarah Yuan - Mar 7, 2022 Form 3 Insider Report for Sigilon Therapeutics, Inc. (SGTX)

Role
CTOO
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
Stock symbol
SGTX
Transactions as of
Mar 7, 2022
Transactions value $
$0
Form type
3
Date filed
3/10/2022, 03:28 PM
Next filing
Apr 4, 2022

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney